These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2493073)

  • 1. The charges for ESRD treatment of diabetics.
    Smith DG; Harlan LC; Hawthorne VM
    J Clin Epidemiol; 1989; 42(2):111-8. PubMed ID: 2493073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment strategies for insulin-dependent diabetics with ESRD: a cost-effectiveness decision analysis model.
    Douzdjian V; Ferrara D; Silvestri G
    Am J Kidney Dis; 1998 May; 31(5):794-802. PubMed ID: 9590189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Payment of USA physicians for dialysis care.
    Kliger AS; Finkelstein FO
    Perit Dial Int; 2004; 24(6):518-20. PubMed ID: 15559477
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of charges for continuous ambulatory peritoneal dialysis and center hemodialysis.
    Smith DG; Wheeler JR
    J Clin Epidemiol; 1988; 41(9):817-24. PubMed ID: 3053998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. End-stage renal disease-associated managed care costs among patients with and without diabetes.
    Joyce AT; Iacoviello JM; Nag S; Sajjan S; Jilinskaia E; Throop D; Pedan A; Ollendorf DA; Alexander CM
    Diabetes Care; 2004 Dec; 27(12):2829-35. PubMed ID: 15562193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of treatment costs between dialysis and transplantation.
    Eggers P
    Semin Nephrol; 1992 May; 12(3):284-9. PubMed ID: 1615249
    [No Abstract]   [Full Text] [Related]  

  • 7. Changing risk factor demographics in end-stage renal disease patients entering hemodialysis and the impact on long-term mortality.
    Collins AJ; Hanson G; Umen A; Kjellstrand C; Keshaviah P
    Am J Kidney Dis; 1990 May; 15(5):422-32. PubMed ID: 2333864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic cost of ESRD, vascular access procedures, and Medicare spending for alternative modalities of treatment. USRDS. United States Renal Data System.
    Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S160-77. PubMed ID: 9259700
    [No Abstract]   [Full Text] [Related]  

  • 9. The organization and financing of kidney dialysis and transplant care in the United States of America.
    Hirth RA
    Int J Health Care Finance Econ; 2007 Dec; 7(4):301-18. PubMed ID: 17602296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective analysis of global costs for maintenance of patients with ESRD.
    Ploth DW; Shepp PH; Counts C; Hutchison F
    Am J Kidney Dis; 2003 Jul; 42(1):12-21. PubMed ID: 12830452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The organization of medical care. Lessons from the Medicare end stage renal disease program.
    Levinsky NG
    N Engl J Med; 1993 Nov; 329(19):1395-9. PubMed ID: 8413437
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical and economic burden of pneumonia in patients enrolled in Medicare receiving dialysis: a retrospective, observational cohort study.
    Sibbel S; Sato R; Hunt A; Turenne W; Brunelli SM
    BMC Nephrol; 2016 Dec; 17(1):199. PubMed ID: 27955633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effective treatment for diabetic end-stage renal disease: dialysis, kidney, or kidney-pancreas transplantation?
    Lenisa L; Castoldi R; Socci C; Motta F; Ferrari G; Spotti D; Caldara R; Secchi A; Pozza G; Di Carlo V
    Transplant Proc; 1995 Dec; 27(6):3108-13. PubMed ID: 8539868
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients.
    Shih YC; Guo A; Just PM; Mujais S
    Kidney Int; 2005 Jul; 68(1):319-29. PubMed ID: 15954923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventable kidney failure: the cost of diabetes neglect?
    Endre ZH; Beaven D; Buttimore A
    N Z Med J; 2006 Dec; 119(1246):U2338. PubMed ID: 17151712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare program; payment for physician outpatient maintenance dialysis services and other physician services for ESRD patients--HCFA. Final rule.
    Fed Regist; 1990 Jun; 55(111):23435-43. PubMed ID: 10106785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ESRD data system needs a fix. Lack of updates impacts beneficiaries, costs Medicare; USRDS looks elsewhere for accurate data.
    Nephrol News Issues; 2002 Apr; 16(5):8, 10. PubMed ID: 11962159
    [No Abstract]   [Full Text] [Related]  

  • 18. The economics of kidney transplantation versus hemodialysis.
    Loubeau PR; Loubeau JM; Jantzen R
    Prog Transplant; 2001 Dec; 11(4):291-7. PubMed ID: 11871278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of end-stage renal disease (ESRD) in diabetes mellitus (DM) in Canada in 1981.
    Posen G; Lam E; Rappoport A
    Trans Am Soc Artif Intern Organs; 1983; 29():116-9. PubMed ID: 6369724
    [No Abstract]   [Full Text] [Related]  

  • 20. The direction of end-stage renal disease reimbursement in the United States.
    Lockridge RS
    Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.